CURE LEUKAEMIA

Registered charity 1100154 · accounts filings on the Charity Commission register

Relief of persons suffering from leukaemia by funding new therapies, treatments and research into and trials of such treatments and providing personnel and facilities for such purposes. Enabling co-operation of scientists and clinicians to develop new and effective treatments for leukaemia. Providing resources information and support groups for leukaemia patients and their families.

Objects

(I) THE RELIEF OF PERSONS SUFFERING FROM LEUKAEMIA.(II) TO UNDERTAKE RESEARCH INTO THE CAUSES, PREVENTION AND TREATMENT OF LEUKAEMIA AND TO PUBLISH THE USEFUL RESULTS OF SUCH RESEARCH.

Area of benefit: NOT DEFINED

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Registered contact address: Birmingham, West Midlands, England (from the postcode on the register)

Latest income
£3.7m
Latest spending
£3.6m
Registered
2003
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported a net surplus of £105,278 for the year ended 31 October 2025, with total unrestricted funds carried forward amounting to £563,068. The trustees consider the present level of funding to be adequate to support the continuation of existing activities and believe no material uncertainties exist regarding going concern. The charity's reserves policy aims to maintain free reserves equivalent to between 6 and 12 months of unrestricted expenditure.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: between 6- and 12-months unrestricted expenditure (held: £563k)
“The charity would like to maintain unrestricted funds not committed or invested in tangible fixed assets, which are the free reserves of the charity, at a level which equates to between 6- and 12-months unrestricted expenditure.” — page 6
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by JW Hinks LLP. Discloses 4 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/10/2025

  • Volunteers: 50
  • Employees paid over £60,000: 3 (£60,001–£70,000: 2; £150,001–£200,000: 1)
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/10/2024

  • Volunteers: 50
  • Employees paid over £60,000: 1 (£150,001–£200,000: 1)
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/10/2023

  • Volunteers: 50
  • Employees paid over £60,000: 1 (£150,001–£200,000: 1)
  • Grant-making is its main activity

Source: this charity’s annual returns on the Charity Commission register.

Public fundraising profile: JustGiving — Cure Leukaemia (matched by registered charity number).

Public profiles (found on the charity’s own website): facebook · instagram

Structured financials (annual return, FY ending 31/10/2025)

Total income
£3.7m
Total spending
£3.6m
Cost of raising funds
£2.5m
Reserves (reported)
£563k
Employees
10

Reported reserves equal ~1.9 months of spending — in the bottom quarter for charities its size (median 4.7 months; benchmarks).

Per its annual return, cost of raising funds: 67.0% of total income — above the 90th percentile for charities its size (median 5.3%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England

Income and spending

Financial year endIncomeSpending
31/10/2025£3.7m£3.6m
31/10/2024£2.9m£2.9m
31/10/2023£2.9m£3.0m
31/10/2022£2.7m£2.3m
31/10/2021£2.3m£2.3m

Common questions

Is CURE LEUKAEMIA financially healthy?

Per its FY2025 accounts: The accounts state that the charity reported a net surplus of £105,278 for the year ended 31 October 2025, with total unrestricted funds carried forward amounting to £563,068. The trustees consider the present level of funding to be adequate to support the continuation of existing activities and believe no material uncertainties exist regarding going concern. The charity's reserves policy aims to maintain free reserves equivalent to between 6 and 12 months of unrestricted expenditure. Its FY2025 accounts were audited by JW Hinks LLP.

Who funds CURE LEUKAEMIA?

Funders whose own accounts filings name CURE LEUKAEMIA as a grant recipient include THE PENNIES FOUNDATION, THE 29TH MAY 1961 CHARITY, BNA CHARITABLE INCORPORATED ORGANISATION, THE SYNCONA FOUNDATION, THE ROAN CHARITABLE TRUST.

Known funders

Grants to this charity found in funders’ own accounts filings.

FunderYearAmountPurpose (as stated by the funder)
THE PENNIES FOUNDATIONFY2023Unverified read£51k
THE PENNIES FOUNDATIONFY2024£44k
THE PENNIES FOUNDATIONFY2025Unverified read£43kGrant to institution
THE 29TH MAY 1961 CHARITYFY2022£30kcosts of a trials coordinator at their centre in Birmingham
BNA CHARITABLE INCORPORATED ORGANISATIONFY2023£25k
THE SYNCONA FOUNDATIONFY2024£20k
THE ROAN CHARITABLE TRUSTFY2022£10kRelief of persons suffering from leukaemia
WSH FOUNDATIONFY2025£8kfunds research and life-saving treatment support at blood cancer centres across the United Kingdom.
THE NOEL SWEENEY FOUNDATIONFY2023Unverified read£5k
THE ROAN CHARITABLE TRUSTFY2021£5kRelief of persons suffering from leukaemia by funding new therapies, treatments and research into and trials of such treatments and providing personnel and faci
FARRER AND CO CHARITABLE TRUSTFY2025£4k
SSP FOUNDATIONFY2021£1k

Grants marked “Unverified read” were flagged by automated checks as possibly misread from the funder’s filed accounts. They are listed, but left out of the totals, counts and funder relationships this site computes.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with LEUKAEMIA CARE.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
CURE LEUKAEMIA£3.7m——unclear—no doubt
LEUKAEMIA CARE FY2025£2.5m——above—no doubt
CANCER CARE AND HAEMATOLOGY FUND FY2025£108k—0unclear—no doubt
TOPIC OF CANCER FY2025£157k—0above—no doubt
NOTTINGHAMSHIRE LEUKAEMIA APPEAL FY2025£45k——unclear—no doubt
LYMPHOMA LEUKAEMIA MYELOMA FUND (WALES) FY2025£49k—0unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.